Evidence map›Paper›PMID 33195168›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Development of a Semi-Automated, Bulk Seeding Device for Large Animal Model Implantation of Tissue Engineered Vascular Grafts.

Eoghan M Cunnane, Katherine L Lorentz, Lorenzo Soletti, Aneesh K Ramaswamy, Timothy K Chung, Darren G Haskett, Samuel K Luketich, Edith Tzeng, Antonio D'Amore, William R Wagner and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Eoghan M CunnaneDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Katherine L LorentzDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Lorenzo SolettiDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Aneesh K RamaswamyDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Timothy K ChungDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Darren G HaskettMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Samuel K LuketichMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Edith TzengDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Antonio D'AmoreMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
William R WagnerDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Justin S WeinbaumDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
David A VorpDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · USRi.MED · IT

Funding

Vascular Surgery Research Training (VascTrain) ProgramT32HL098036 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Edith Tzeng · 2010 to 2026
$7.2M
Preclinical optimization and design for manufacturability of immunoregulatory tissue-engineered vascular graftsR61HL154102 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2020 to 2021
$757k
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular GraftR21HL130784 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2016 to 2017
$418k
The Role of Fibrinolysis in Tissue Engineered Vascular Grafts for Aged IndividualsR21AG061430 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2020 to 2021
$394k
NHLBI NIH HHS R21 HL130784NHLBI NIH HHS R61 HL154102NHLBI NIH HHS T32 HL098036NIA NIH HHS R21 AG061430
6 · The paper itself

Abstract

Vascular tissue engineering is a field of regenerative medicine that restores tissue function to defective sections of the vascular network by bypass or replacement with a tubular, engineered graft. The tissue engineered vascular graft (TEVG) is comprised of a biodegradable scaffold, often combined with cells to prevent acute thrombosis and initiate scaffold remodeling. Cells are most effectively incorporated into scaffolds using bulk seeding techniques. While our group has been successful in uniform, rapid, bulk cell seeding of scaffolds for TEVG testing in small animals using our well-validated rotational vacuum technology, this approach was not directly translatable to large scaffolds, such as those required for large animal testing or human implants. The objective of this study was to develop and validate a semi-automated cell seeding device that allows for uniform, rapid, bulk seeding of large scaffolds for the fabrication of TEVGs appropriately sized for testing in large animals and eventual translation to humans. Validation of our device revealed successful seeding of cells throughout the length of our tubular scaffolds with homogenous longitudinal and circumferential cell distribution. To demonstrate the utility of this device, we implanted a cell seeded scaffold as a carotid interposition graft in a sheep model for 10 weeks. Graft remodeling was demonstrated upon explant analysis using histological staining and mechanical characterization. We conclude from this work that our semi-automated, rotational vacuum seeding device can successfully seed porous tubular scaffolds suitable for implantation in large animals and provides a platform that can be readily adapted for eventual human use.

Indexed as

bulk seedingcarotid implantationmesenchyaml stem cellssheep modelvascular tissue engineering

Identifiers

PMID33195168
PMCPMC7644804
OpenAlexW3093655088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.